Company Filing History:
Years Active: 1999-2000
Title: Innovations by Fahad A Al-Abdaly
Introduction
Fahad A Al-Abdaly is an accomplished inventor based in Torrance, CA. He has made significant contributions to the field of cell selection technologies, holding 2 patents that enhance the efficiency of cell purification processes. His work is particularly relevant in the context of cancer treatment and regenerative medicine.
Latest Patents
Al-Abdaly's latest patents focus on methods for positive and positive/negative cell selection mediated by peptide release. The first patent describes a non-enzymatic method for releasing cells selected from a heterogeneous cell suspension through antibody-mediated binding to solid supports. This method involves forming a complex with a primary monoclonal antibody linked to a solid support, which binds to a specific cell surface antigen on target cells. The complex is then separated from the suspension and treated with a specific peptide that displaces the antibody, effectively releasing the target cell. The second patent similarly outlines a method for positively selecting CD34+ hematopoietic stem cells while purging undesired tumor cells or lymphocytes from the selected population. This purified cell composition is crucial for reinfusion into cancer patients following high-dose therapy, aiding in the reconstitution of their immune systems.
Career Highlights
Fahad A Al-Abdaly has established himself as a key figure in the biotechnology sector, particularly through his work at Nexell Therapeutics Inc. His innovative approaches to cell selection have the potential to significantly impact therapeutic strategies in oncology and regenerative medicine.
Collaborations
Al-Abdaly collaborates with notable colleagues such as Janet Tseng-Law and Joan A Kobori, contributing to a dynamic research environment that fosters innovation and advancement in cell therapy technologies.
Conclusion
Fahad A Al-Abdaly's contributions to cell selection methodologies represent a significant advancement in the field of biotechnology. His patents not only enhance the efficiency of cell purification but also hold promise for improving patient outcomes in cancer treatment.